Advances in Traditional Medicine

  • 제8권4호
  • /
  • Pages.408-415
  • /
  • 2008
  • /
  • 2662-4052(pISSN)
  • /
  • 2662-4060(eISSN)
경희대학교 융합한의과학연구소 (Kyung Hee Oriental Medicine Research Center)
권호 표지
DOI QR코드

DOI QR Code

Search towards an insight for comparative anti-tumour effects of Wrightia tomentosa leaf & bark in ehrlich ascites carcinoma bearing mice

  • Nagarajan, K (Division of Medicinal chemistry R & D Laboratory, Department of Pharmacy, IIMT College of Medical Sciences) ;
  • Mazumder, Avijit (Division of Clinical Pharmacy & Pharmacology, School of pharmacy Technology & Management, NMIMS University) ;
  • Ghosh, LK (Division of Pharmaceutics, Department of Pharmaceutical Technology, Jadavpur University)
  • 발행 : 2008.12.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

In the present study, the ethanolic leaf and bark extract of Wrightia tomentosa were tested for comparative in vivo antitumour properties against Ehrlich ascites carcinoma (EAC) tumour bearing mice at 100 and 200 mg/kg body weight doses given orally once daily for 16 days. The EAC mice receiving 100 and 200 mg/kg ethanolic leaf and bark extract showed a dose dependent elevation in tumour, free survival and a highest number of survivors were observed at 200 mg/ kg for leaf extract of ethanol, which was considered as an optimum dose for its anti neoplastic action. The Median survival time for this dose was approximately 44 days when compared with 23 days of non-drug treated controls. The results indicate that the administration of leaf extract not only increased the survival of animals with ascites tumour and reduced packed cell volume and viable tissue cell count, but also altered many hematological parameters changed during tumour progression, indicating the potent antitumour nature of leaf extract than the bark extract. Statistical analysis also reveals that the leaf extract showed highly significant anti tumour potency (p < 0.001) when compared with control.

키워드

참고문헌

  1. Ahluwalia GS, Cooney DA, Jayaram HN, Johns DG, Plowhan JP. (1984) Studies on the mechanism of action of 2-β-D-ribofuranosyl thiazole-4-carboxamide-V:Factors governing the response of murine tumours to tiazofurin. Biochem. Pharmacol. 33, 1195-1203 https://doi.org/10.1016/0006-2952(84)90170-9
  2. Akamanchi KG, Beena Pannikar, Pannikar KR, Sathish Nair C. (1991) Inhibitory effects of Ixora javanica extract on skin chemical carcinogenesis in mice and its antitumour activity. Cancer Lett. 60, 253-258 https://doi.org/10.1016/0304-3835(91)90121-W
  3. Alley MC, Dykes DJ, Hollingshead M, Plowman J, Simpson HL. (1995) Human tumour xenograft models in NCI drug development. In: Anticancer drug development guide: preclinical screening, clinicaltrials, and approval Totawa: Humana, edited by Teicher B, p.101, USA
  4. Anonymous (1978) Screening Data Summary Interpretation, pp.14, U.S. Natl. Cancer. Inst. Instruciton, USA
  5. Anonymous. (1985) The wealth of India: Raw material, pp.590, Vol.1A, Index- 175, CSIR publications., New Delhi
  6. Barbero LG, Marquez J, Segura JA. (2000) Ehrlich ascites tumour unbalances splenic cell population and reduces responsiveness of T cells to Staphylococcus aureus enterotoxin B stimulation. Immunology Lett. 74, 111-115 https://doi.org/10.1016/S0165-2478(00)00208-X
  7. Basu BD, Kirtikar KR. (1973) Indian Medicinal Plants, pp.1583, $2^{nd}$ Edn., Vol.III, International Book Distributors., Dehradun
  8. Basu BD (1991) Indian Medicinal Plants, pp.612, Part III, Bishen Singh Mahendra Pal Singh Publishers., Dehradun
  9. Brandner G, Fritsche M, Hess RD, Plaumann B, Rimpler H. (1996) Flavonoids activate wild- type p53. Oncogene 13, 1605-1614
  10. Cragg GM, Newman DJ, Snader KM. (2000) The influence of natural products upon drug discovery. Nat. Prod. Rep. 17, 215-234 https://doi.org/10.1039/a902202c
  11. Cragg GM, Newman DJ. (2005) Plants as a source of anti-cancer agents. J. Ethnopharmacol. 100, 72-79 https://doi.org/10.1016/j.jep.2005.05.011
  12. Czyz J, Hulser DF, Irmer U, Mauz M, Zappe C. (2004) Hierarchy of carcinoma cell responses to apigenin: gap junctional coupling versus proliferation. Oncol. Rep. 11, 739-744
  13. Dacie JV. (1958) Practical Hematology, pp.38, J & A Churchill Ltd., London
  14. Da Rocha AB, Mans DR, Schwartsmann G. (2000) Anti- cancer drug discovery and development in Brazil: Targeted plant collection as a rational strategy to acquire candidate anti- cancer compounds. Oncologist 5, 185-198 https://doi.org/10.1634/theoncologist.5-3-185
  15. Dilip KG, Pratima S. (1994) Tea plant root extract as an antineoplastic agent. Planta Med. 60, 106-109 https://doi.org/10.1055/s-2006-959427
  16. Fecchio D, Janear S, Russo M, Sirois P. (1990) Studies on inflammatory response induced by Ehrlich tumour in mice peritoneal cavity.Inflammation 14, 125-131 https://doi.org/10.1007/BF00914035
  17. Fleischer S, Hogberg J, Moldeus P, Orrhenius S, Parker L. (1978) Methods in Enzymology, pp. 60-71, Vol 52, Academic Press., New York
  18. Geoffrey AC, Gulacti T, Hermann L, Hildebert W, John MP, Lee-Juian L, Nijsiri R. (1992) Wrightiadione from Wrightia tomentosa. Phytochemistry 31, 4333-4335 https://doi.org/10.1016/0031-9422(92)80469-U
  19. Giri A, Prasad SB. (1994) Antitumour effect of Cisplatin against murine ascites Dalton's lymphoma. Indian J. Exp. Biol. 32, 155-162
  20. Harry LB, James AD, Leland JC, Peter BK, Sara W. (1999) Natural products from plants, pp.158, CRC press, New York
  21. Kao MC, Lin JK, Way TD. (2005) Degradation of HER2/neu by apigenin induces apoptosis through cytochrome c release and caspase -3 activation in HER 2/neu-overexpressing breast cancer cells. FEBS Lett. 579, 145-152 https://doi.org/10.1016/j.febslet.2004.11.061
  22. Kintzios SE. (2006) Terrestrial plant derived anticancer agents and plants used in anticancer research. Crit. Rev. Plant Sci. 25, 79-113 https://doi.org/10.1080/07352680500348824
  23. Kobayashi K, Pillai SK. (2003) Applied Statistics in Toxicology and Pharmacology, pp.19, Oxford & IBH Publishing Co.Pvt. Ltd., New Delhi
  24. Kokura S, Kondo M, Naito Y, Tainaka K, Yoshikawa T. (1999) A novel cancer therapy based on oxygen radicals. Cancer Res. 55, 1617-1620
  25. Matsukawa Y, Matsumoto K, Nishino H, Sakai T and Sato F. (1994) Apigenin induces morphological differentiation and G2–M arrest in rat neuronal cells. Biochem. Biophys. Res. Commun. 204, 578-584 https://doi.org/10.1006/bbrc.1994.2498
  26. Matthew KM. (1982) Illustrations on the Flora of the Tamilnadu Carnatic, pp.973, Vol.2, The Diocesan Press, Madras
  27. Minami M, Onodera s, Tashiro S, Wang D, Wang M, Xia M, Ikejima T. (2004) Dracorhodin percholarate induces apoptosis via activation of caspases and generation of reactive oxygen species. J. Pharmacol. Sci. 95, 273-283 https://doi.org/10.1254/jphs.FPJ03102X
  28. Nadkarni AK, Nadkarni KM. (1976) Indian Materia Medica, pp.849, $3^{rd}$ Edn., Vol. I Popular Prakashan., Bombay
  29. Nagarajan K, Mazumder A, Ghosh LK. (2006) Comparative anti-microbial evaluation studies of the extracts and isolates of leaves & bark of Wrightia tomentosa. Ancient Sci. Life. 26, 12-18
  30. Nagarajan K, Mazumder A, Ghosh LK. (2007) Comparative anti-allodynic effects and toxicity studies for the herbal Wrightia tomentosa leaf & bark in Swiss albino mice. Pharmacologyonline 3, 294-307
  31. Nagarajan K, Mazumder A, Ghosh LK. (2007) Toxicological evaluation and antinociceptive effects of Wrightia tomentosa in mice. Nigerian J. Nat. Prod. Med. 11, 64-66
  32. Nagarajan K, Mazumder A, Ghosh LK. (2008) Invitro antioxidant activity of alcoholic extracts of Wrightia tomentosa. Pharmacologyonline 1, 196-203
  33. Nagarajan K, Mazumder A, Ghosh LK. (2008) Evaluation of anti-tubercular activity directly from Versa TREK mycobottles using Wrightia tomentosa alcoholic extracts. Pharmacologyonline 1, 486-496
  34. Nagarajan K, Mazumder A, Ghosh LK. (2008) Comparative antihyperglycemic activity of alcoholic leaf and bark extract of Wrightia tomentosa in streptozotocin induced diabetic rats. J. Cell. Tissue Res. 8, 1289-1292
  35. Ranajit Sen. (2004) Principles and Management of Cancer – A Practical Guide, pp.3, B.I. Publications Pvt. Ltd., New Delhi
  36. Rates SM. (2001) Plants as source of drugs. Toxicon. 39, 603-613 https://doi.org/10.1016/S0041-0101(00)00154-9
  37. Sammbamurty AVSS, Subrahmanyam NS. (1994) Medicinal plants in Industry, pp.9, Ist Edn., CBS Publishers & Distributors., New Delhi
  38. Talwar GP. (1974) Hand Book of Practical Immunology, pp. 329-336, National Book Trust., New Delhi